What is the therapeutic target level of 25-hydroxyvitamin D in osteoporosis and how accurately can we measure it?

Paul Glendenning, Richard Prince

Research output: Contribution to journal › Review article

2 Citations (Scopus)

Original language	English
Pages (from-to)	1069-1072
Journal	Internal Medicine Journal
Volume	42
DOIs	https://doi.org/10.1111/j.1445-5994.2012.02908.x
Publication status	Published - 2012

Cite this

Glendenning, P., & Prince, R. (2012). What is the therapeutic target level of 25-hydroxyvitamin D in osteoporosis and how accurately can we measure it? Internal Medicine Journal, 42, 1069-1072. https://doi.org/10.1111/j.1445-5994.2012.02908.x

@article{4f0ca2dadf7f45609a293e7eb927a384,

title = "What is the therapeutic target level of 25-hydroxyvitamin D in osteoporosis and how accurately can we measure it?",

author = "Paul Glendenning and Richard Prince",

year = "2012",

doi = "10.1111/j.1445-5994.2012.02908.x",

language = "English",

volume = "42",

pages = "1069--1072",

journal = "Internal Medicine Journal (Print)",

issn = "1444-0903",

publisher = "John Wiley & Sons",

}

TY - JOUR

T1 - What is the therapeutic target level of 25-hydroxyvitamin D in osteoporosis and how accurately can we measure it?

AU - Glendenning, Paul

AU - Prince, Richard

PY - 2012

Y1 - 2012

U2 - 10.1111/j.1445-5994.2012.02908.x

DO - 10.1111/j.1445-5994.2012.02908.x

M3 - Review article

VL - 42

SP - 1069

EP - 1072

JO - Internal Medicine Journal (Print)

JF - Internal Medicine Journal (Print)

SN - 1444-0903

ER -

Access to Document

10.1111/j.1445-5994.2012.02908.x